Transcriptional and non-transcriptional functions of IRF3 in ALD

IRF3 在 ALD 中的转录和非转录功能

基本信息

  • 批准号:
    10207370
  • 负责人:
  • 金额:
    $ 47.99万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-07-05 至 2023-06-30
  • 项目状态:
    已结题

项目摘要

ABSTRACT Alcohol consumption is a leading cause of preventable morbidity and mortality worldwide. Chronic alcohol abuse underlies the pathogenesis of alcoholic liver disease (ALD), encompassed by a spectrum of pathologies, ranging from steatosis, to more severe forms of liver injury, including alcoholic hepatitis (AH), fibrosis, and cirrhosis. There is a growing appreciation of a dynamic and complex role of the innate immune system in the progression of ALD, as well as the resolution of hepatocellular injury and fibrosis. The controlled and appropriate resolution of inflammation is an essential feature of the innate immune response. This dynamic interplay between injury and repair is mediated, at least in part, by the tremendous plasticity of resident tissue macrophages and infiltrating monocytes as they respond to signals within their microenvironment. Signaling via IRF3 is an important element in the dynamic regulation of pro-survival vs pro-death pathways in immune cells. While several studies have implicated IRF3 in the progression of ALD, the mechanisms by which IRF3 contributes to liver injury are not well understood. Classically, IRF3 is known as a transcription factor essential for the induction of interferon- (IFN-) and antiviral genes. Recently, members of our team discovered that, in addition to its transcriptional functions, IRF3 directly triggers a pro-apoptotic pathway, termed RIG-I- like receptors (RLR)-induced IRF-3-mediated pathway of apoptosis (RIPA) via a non-transcriptional mechanism. In IRF3-mediated apoptosis, IRF3 is activated by linear ubiquitination on two lysine residues, resulting in the interaction of IRF3 with the pro-apoptotic protein Bax. The IRF3/BAX complex then translocates to the mitochondria where it triggers apoptosis. In order to study this pathway, we have generated a novel knock-in mouse that expresses an IRF3 protein that only exhibits non-transcriptional functions. Importantly, in preliminary experiments, we discovered that IRF3-mediated apoptosis of innate immune cells recruited to the liver in response to Gao-binge ethanol exposure dynamically exacerbates inflammation and contributes to murine alcoholic hepatitis (mAH). Here we propose to investigate the mechanisms by which the non-transcriptional activity of IRF3 contributes to both hepatic inflammation and fibrosis in models of mAH and fibrosis in 2 specific aims: SA1) Determine the contribution of the non-transcriptional function of IRF3 in mediating ethanol-induced liver injury in the Gao-binge model of mAH and a murine model of acceleration of fibrosis by ethanol and SA2) Investigate the mechanisms of IRF3 activation in immune cells during mAH or fibrosis. In summary, our studies will reveal novel roles for the non-transcriptional activity of IRF3 in exacerbating innate immune responses to alcohol, as well as identify potential therapeutic targets that would prevent and/or improve the resolution of inflammation and fibrosis in patients with ALD.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LAURA E. NAGY其他文献

LAURA E. NAGY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LAURA E. NAGY', 18)}}的其他基金

IRAKM and MINCLE in ALD
ALD 中的 IRAKM 和 MINCLE
  • 批准号:
    10750123
  • 财政年份:
    2023
  • 资助金额:
    $ 47.99万
  • 项目类别:
Transcriptional and non-transcriptional functions of IRF3 in ALD
IRF3 在 ALD 中的转录和非转录功能
  • 批准号:
    10430300
  • 财政年份:
    2019
  • 资助金额:
    $ 47.99万
  • 项目类别:
Transcriptional and non-transcriptional functions of IRF3 in ALD
IRF3 在 ALD 中的转录和非转录功能
  • 批准号:
    10173028
  • 财政年份:
    2019
  • 资助金额:
    $ 47.99万
  • 项目类别:
Transcriptional and non-transcriptional functions of IRF3 in ALD
IRF3 在 ALD 中的转录和非转录功能
  • 批准号:
    9765602
  • 财政年份:
    2019
  • 资助金额:
    $ 47.99万
  • 项目类别:
Microbial metabolites and Innate Immunity in AH: Biomarkers of injury and repair
AH 中的微生物代谢物和先天免疫:损伤和修复的生物标志物
  • 批准号:
    10428502
  • 财政年份:
    2018
  • 资助金额:
    $ 47.99万
  • 项目类别:
Specific-sized hyaluronan: a dual targeted therapy for ALD
特定大小的透明质酸:ALD 的双重靶向治疗
  • 批准号:
    10227144
  • 财政年份:
    2018
  • 资助金额:
    $ 47.99万
  • 项目类别:
Specific-sized hyaluronan: a dual targeted therapy for ALD
特定大小的透明质酸:ALD 的双重靶向治疗
  • 批准号:
    9753072
  • 财政年份:
    2018
  • 资助金额:
    $ 47.99万
  • 项目类别:
Specific-sized hyaluronan: a dual targeted therapy for ALD
特定大小的透明质酸:ALD 的双重靶向治疗
  • 批准号:
    10457954
  • 财政年份:
    2018
  • 资助金额:
    $ 47.99万
  • 项目类别:
Microbial metabolites and Innate Immunity in AH: Biomarkers of injury and repair
AH 中的微生物代谢物和先天免疫:损伤和修复的生物标志物
  • 批准号:
    9791131
  • 财政年份:
    2018
  • 资助金额:
    $ 47.99万
  • 项目类别:
Specific-sized hyaluronan: a dual targeted therapy for ALD
特定大小的透明质酸:ALD 的双重靶向治疗
  • 批准号:
    9977058
  • 财政年份:
    2018
  • 资助金额:
    $ 47.99万
  • 项目类别:

相似海外基金

Insula-amygdala circuits in alcohol abuse
酒精滥用中的岛杏仁核回路
  • 批准号:
    10735851
  • 财政年份:
    2023
  • 资助金额:
    $ 47.99万
  • 项目类别:
A novel animal model to study the association between alcohol abuse during late adolescence with common conditions observed in combat Veterans
一种新的动物模型,用于研究青春期后期酗酒与退伍军人中观察到的常见状况之间的关联
  • 批准号:
    10644999
  • 财政年份:
    2022
  • 资助金额:
    $ 47.99万
  • 项目类别:
Reinforcement as a Prospective Predictor of Real-time Alcohol Abuse Following Bariatric Surgery
强化作为减肥手术后实时酒精滥用的前瞻性预测因子
  • 批准号:
    10370120
  • 财政年份:
    2022
  • 资助金额:
    $ 47.99万
  • 项目类别:
ACSS2 inhibition in treating Alcohol Abuse
ACSS2 抑制治疗酒精滥用
  • 批准号:
    10546942
  • 财政年份:
    2022
  • 资助金额:
    $ 47.99万
  • 项目类别:
A novel animal model to study the association between alcohol abuse during late adolescence with common conditions observed in combat Veterans
一种新的动物模型,用于研究青春期后期酗酒与退伍军人中观察到的常见状况之间的关联
  • 批准号:
    10368295
  • 财政年份:
    2022
  • 资助金额:
    $ 47.99万
  • 项目类别:
Reinforcement as a Prospective Predictor of Real-time Alcohol Abuse Following Bariatric Surgery
强化作为减肥手术后实时酒精滥用的前瞻性预测因子
  • 批准号:
    10705563
  • 财政年份:
    2022
  • 资助金额:
    $ 47.99万
  • 项目类别:
The Functional Implications of Astrocytic GPCR-signaling on Alcohol Abuse
星形胶质细胞 GPCR 信号传导对酒精滥用的功能影响
  • 批准号:
    10472456
  • 财政年份:
    2021
  • 资助金额:
    $ 47.99万
  • 项目类别:
Trauma and Neurobiological Threat Reactivity as Risk Factors for Alcohol Abuse in Youth
创伤和神经生物学威胁反应作为青少年酗酒的危险因素
  • 批准号:
    10582520
  • 财政年份:
    2021
  • 资助金额:
    $ 47.99万
  • 项目类别:
Trauma and Neurobiological Threat Reactivity as Risk Factors for Alcohol Abuse in Youth
创伤和神经生物学威胁反应作为青少年酗酒的危险因素
  • 批准号:
    10368089
  • 财政年份:
    2021
  • 资助金额:
    $ 47.99万
  • 项目类别:
The Functional Implications of Astrocytic GPCR-signaling on Alcohol Abuse
星形胶质细胞 GPCR 信号传导对酒精滥用的功能影响
  • 批准号:
    10089613
  • 财政年份:
    2021
  • 资助金额:
    $ 47.99万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了